QIPP, Efficiency & Savings


GS1 standards: a weapon against counterfeit drugs

Source: NHE Jul/Aug 2017

Glen Hodgson, head of healthcare at GS1 UK, explores the rising problem of counterfeit drugs and the legislation being introduced to tackle it.

Counterfeit drugs are a global problem. World Health Organization data puts the sales of counterfeit drugs at over $75bn every year, with more than 50% of drugs sold online being falsified. And, in case you think this doesn’t affect us in the UK, the nation’s medicines regulator, the MHRA, seized over 12,000,000 fake or unlicensed products in the first half of last year and they’ve shut down more than 2,000 online pharmacies. You also probably know someone who is vulnerable – one in eight British people, aged between 18-30, have said they’re likely to buy diet pills online in the next 12 months. 

As you’d expect, countries all over the world are doing their best to combat this and legislation around labelling requirements for medicines is establishing how best to win the battle. The key focus for regulators is the need to identify and trace pharmaceutical products, so that we know the medicine is what it says it is and can see exactly where it has come from. More specifically in Europe, this has taken the form of the Falsified Medicines Directive (FMD), which requires a unique identifier to be placed on all medical products. And if you’re wondering about Brexit, the legislation comes into effect in February 2019 so we’ll need to be compliant at that point. But realistically, similar legislation is being brought in around the world so there’s no reason to think an independent UK wouldn’t need to keep up. 

How standards make a difference 

The FMD asks for all manufacturers of pharmaceuticals to put a two-dimensional barcode on the packaging of all products. This identifies the product, expiry date, batch number and serial number, and must appear in ‘human readable format’ too. It’s here that GS1 standards make the difference – the GS1 2D DataMatrix was chosen by the European Federation of Pharmaceutical Industries and Associations as its data carrier of choice, because of the need for globally unique codes to identify and authenticate these products. 

GS1 standards bring the interoperability and means that manufacturers, suppliers, pharmacies and hospitals are all speaking the same language, using the same standards, and ensuring that they can work across markets, stakeholders and sectors. It’s why the Department of Health has mandated the use of our standards in all acute trusts in England – to uniquely identify every person, product and place. And it’s another reason for suppliers to the NHS to become GS1-compliant as it will be written into their NHS contracts that they need to be so.

These changes represent an enormous change for pharmacy practice – but they also provide a fantastic opportunity for improving safety. They guarantee that every pack of medicine can be checked and verified at every stage of the supply chain. And in the case of a product recall, a product can be identified down to the individual packet, so healthcare professionals can know where drugs have come from, who has administered them and who they’ve come into contact with. The standards are a weapon against counterfeiting because they stop falsified medicines from even getting that far – they’re checked and verified at every point along the way.

These standards are already embedded in the retail sector, they’ve been using them for over 40 years. And the accurate data this brings benefits everyone, making for a more efficient and effective supply chain. The level of traceability we find in retail is what we’re now aiming for in healthcare, giving the healthcare system a common foundation for enhancing care delivery and ensuring patient safety.


W: www.gs1uk.org/healthcare


There are no comments. Why not be the first?

Add your comment


national health executive tv

more videos >

latest healthcare news

Councillors fear identity crisis following CCG merger

22/06/2018Councillors fear identity crisis following CCG merger

Members of one of Kent’s leading councils have voiced their concerns against an upcoming merger between CCGs in the area. Cllr Wendy P... more >
Top NHS England boss to leave the organisation

22/06/2018Top NHS England boss to leave the organisation

NHS England’s chief financial officer will leave the post after 11 years. Paul Baumann CBE, who joined NHS London in 2007, and took up... more >
Most urgent primary care services ‘good’ or ‘outstanding’

22/06/2018Most urgent primary care services ‘good’ or ‘outstanding’

Over eight in 10 primary care services are providing good care, despite mounting work force and commissioning pressures, the CQC has said. A... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital exemplars who were revealed at the same show 12 months earlier.  Jeremy Hunt also stated th... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

the scalpel's daily blog

The impact of NICE on cardiovascular disease prevention

06/06/2018The impact of NICE on cardiovascular disease prevention

Professor Gillian Leng, deputy chief executive and director Health and Social Care at NICE, looks into what can be done to decrease cardiovascular disease nationally and how to prevent missed opportunities in the future. Cardiovascular disease (CVD) accounts for just over a quarter of deaths and affects around 7 million people in the UK. ... more >
read more blog posts from 'the scalpel' >


Getting more out of our medicines

20/06/2018Getting more out of our medicines

Paul Chrisp, programme director of medicines and technologies at NICE, describes how the organisation is re-purposing drugs in order to improve p... more >
Under attack

20/06/2018Under attack

One attack against an NHS worker is one too many. But unfortunately, the trend in recent years has been alarmingly upwards, with no part of the N... more >
Lessons from WannaCry

20/06/2018Lessons from WannaCry

Sir Geoffrey Clifton-Brown, a member of the Public Accounts Committee, warns that the UK Government must take seriously the threat of a more soph... more >
A hostile environment

20/06/2018A hostile environment

Dr Terry John, chair of the BMA’s international committee, gives his thoughts on the government’s visa and immigration policy and its... more >


Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >
Tackling infection prevention locally

04/10/2017Tackling infection prevention locally

Dr Emma Burnett, a lecturer and researcher in infection prevention at the University of Dundee’s School of Nursing and Midwifery and a boar... more >
Scan4Safety: benefits across the whole supply chain

02/10/2017Scan4Safety: benefits across the whole supply chain

NHE interviews Gillian Fox, head of eProcurement (Scan4Safety) programme at NHS Supply Chain. How has the Scan4Safety initiative evolved sin... more >

health service focus

View all News